Corcept Therapeutics Inc
NASDAQ:CORT

Watchlist Manager
Corcept Therapeutics Inc Logo
Corcept Therapeutics Inc
NASDAQ:CORT
Watchlist
Price: 83.76 USD 2.72% Market Closed
Market Cap: 8.8B USD

Intrinsic Value

The intrinsic value of one CORT stock under the Base Case scenario is 116.36 USD. Compared to the current market price of 83.76 USD, Corcept Therapeutics Inc is Undervalued by 28%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CORT Intrinsic Value
116.36 USD
Undervaluation 28%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Corcept Therapeutics Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about CORT?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is CORT valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Corcept Therapeutics Inc.

Explain Valuation
Compare CORT to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about CORT?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Corcept Therapeutics Inc

Current Assets 541.1m
Cash & Short-Term Investments 424.2m
Receivables 69.6m
Other Current Assets 47.3m
Non-Current Assets 282.5m
Long-Term Investments 102.6m
PP&E 6.9m
Other Non-Current Assets 173.1m
Current Liabilities 172.3m
Accounts Payable 34.4m
Accrued Liabilities 137.8m
Non-Current Liabilities 19.4m
Other Non-Current Liabilities 19.4m
Efficiency

Free Cash Flow Analysis
Corcept Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Corcept Therapeutics Inc

Revenue
741.2m USD
Cost of Revenue
-13.4m USD
Gross Profit
727.8m USD
Operating Expenses
-662.2m USD
Operating Income
65.6m USD
Other Expenses
40.5m USD
Net Income
106.1m USD
Fundamental Scores

CORT Profitability Score
Profitability Due Diligence

Corcept Therapeutics Inc's profitability score is 61/100. The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROIC
Exceptional Gross Margin
Positive 3Y Average ROE
Strong 3Y Average Gross Margin
61/100
Profitability
Score

Corcept Therapeutics Inc's profitability score is 61/100. The higher the profitability score, the more profitable the company is.

CORT Solvency Score
Solvency Due Diligence

Corcept Therapeutics Inc's solvency score is 78/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Low D/E
Short-Term Solvency
78/100
Solvency
Score

Corcept Therapeutics Inc's solvency score is 78/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CORT Price Targets Summary
Corcept Therapeutics Inc

Wall Street analysts forecast CORT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CORT is 137.93 USD with a low forecast of 122.21 USD and a high forecast of 152.15 USD.

Lowest
Price Target
122.21 USD
46% Upside
Average
Price Target
137.93 USD
65% Upside
Highest
Price Target
152.15 USD
82% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Corcept Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for CORT is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

CORT Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one CORT stock?

The intrinsic value of one CORT stock under the Base Case scenario is 116.36 USD.

Is CORT stock undervalued or overvalued?

Compared to the current market price of 83.76 USD, Corcept Therapeutics Inc is Undervalued by 28%.

Back to Top